Concourse Financial Group Securities’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7955 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8246 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 8245 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8255 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8257 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8191 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7990 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7786 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7510 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7519 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7343 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7244 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7105 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6997 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6772 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6531 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6309 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6111 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5900 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5746 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5679 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5594 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5427 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5485 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5390 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5294 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5110 |
|